tiprankstipranks
Trending News
More News >
Laboratorios Farmaceuticos Rovi, SA (ES:ROVI)
BME:ROVI
Spanish Market

Laboratorios Farmaceuticos Rovi (ROVI) Financial Statements

Compare
39 Followers

Laboratorios Farmaceuticos Rovi Financial Overview

Laboratorios Farmaceuticos Rovi's market cap is currently €3.99B. The company's EPS TTM is €0.834; its P/E ratio is 23.13; and it has a dividend yield of 1.50%. Laboratorios Farmaceuticos Rovi is scheduled to report earnings on February 25, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 743.48M€ 763.75M€ 829.51M€ 817.70M€ 648.68M
Gross Profit€ 451.65M€ 478.35M€ 483.34M€ 519.61M€ 384.82M
Operating Income€ 173.14M€ 179.54M€ 220.25M€ 255.85M€ 181.57M
EBITDA€ 203.52M€ 207.69M€ 245.81M€ 281.49M€ 204.72M
Net Income€ 140.44M€ 136.88M€ 170.34M€ 199.67M€ 153.08M
Balance Sheet
Cash & Short-Term Investments€ 97.98M€ 27.41M€ 25.32M€ 124.94M€ 99.03M
Total Assets€ 955.69M€ 832.02M€ 799.88M€ 878.70M€ 732.68M
Total Debt€ 146.09M€ 114.41M€ 65.43M€ 72.14M€ 73.14M
Net Debt€ 48.11M€ 87.22M€ 40.10M€ -52.81M€ -25.89M
Total Liabilities€ 276.79M€ 250.48M€ 256.39M€ 357.32M€ 261.70M
Stockholders' Equity€ 664.41M€ 572.03M€ 539.39M€ 520.01M€ 470.98M
Cash Flow
Free Cash Flow€ 120.16M€ 76.06M€ 58.06M€ 186.21M€ 108.50M
Operating Cash Flow€ 185.37M€ 138.28M€ 113.25M€ 237.60M€ 149.44M
Investing Cash Flow€ -67.56M€ -81.06M€ -52.03M€ -57.15M€ -40.84M
Financing Cash Flow€ -47.02M€ -55.36M€ -160.84M€ -154.54M€ -62.73M
Currency in EUR

Laboratorios Farmaceuticos Rovi Earnings and Revenue History

Laboratorios Farmaceuticos Rovi Debt to Assets

Laboratorios Farmaceuticos Rovi Cash Flow

Laboratorios Farmaceuticos Rovi Forecast EPS vs Actual EPS